BrukerBRKR
Market Cap: $9.69B
About: Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Employees: 9,707
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
359% more call options, than puts
Call options by funds: $8.79M | Put options by funds: $1.91M
36% more repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 115
3.79% less ownership
Funds ownership: 80.29% [Q1] → 76.51% (-3.79%) [Q2]
7% less funds holding
Funds holding: 383 [Q1] → 358 (-25) [Q2]
29% less capital invested
Capital invested by funds: $10.4B [Q1] → $7.38B (-$3B) [Q2]
32% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 78
50% less funds holding in top 10
Funds holding in top 10: 6 [Q1] → 3 (-3) [Q2]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Wells Fargo Brandon Couillard 36% 1-year accuracy 4 / 11 met price target | 22%upside $78 | Overweight Initiated | 27 Aug 2024 |
TD Cowen Max Masucci 0 / 0 met price target | 12%upside $72 | Hold Maintained | 7 Aug 2024 |
Citigroup Patrick Donnelly 72% 1-year accuracy 23 / 32 met price target | 25%upside $80 | Buy Maintained | 10 Jul 2024 |
Goldman Sachs Matthew Sykes 70% 1-year accuracy 37 / 53 met price target | 6%downside $60 | Sell Maintained | 9 Jul 2024 |
Financial journalist opinion
Based on 10 articles about BRKR published over the past 30 days